KL

Kck LTD.

Concentrated strategyLong-term holderQuality / disciplined sizing

Total reported value

$15.1M

Reporting period: 2025-09-30 · Number of holdings: 2

KCK LTD. disclosed 2 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of $15.1M and a quarterly turnover rate of 0.0%.

Browse other institutions with under $100M AUMBrowse other institutions starting with "K"

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
4
Sizing Uniformity
85.96

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1SGHTSight Sciences INCStock-Other99.66%
2RNTXRein Therapeutics INCStock-Other0.34%

Holding changes this quarter

Position changes disclosed by Kck LTD. for the quarter ending 2025-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Kck LTD. and what type of investor is it?
Kck LTD. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-09-30), the firm manages a tracked equity portfolio valued at approximately $15.1M, spread across 2 disclosed positions.
What are Kck LTD.'s largest equity positions?
Based on the latest 13F filing, Kck LTD.'s top holdings by market value are: 1. Sight Sciences INC (SGHT) — $15.0M (99.7%) 2. Rein Therapeutics INC (RNTX) — $52.1K (0.3%)
What changes did Kck LTD. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Kck LTD. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Kck LTD. focus on?
Sector breakdown data is not yet available for Kck LTD.. Check back after the next 13F processing cycle.